This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Mar;102(3):349-350.

doi: 10.1097/TP.0000000000002037.

Mitigating Risk of Immunosuppression by Immune Monitoring: Are We There?

Andrew Bentall¹, Hatem Amer¹

Affiliations

PMID: 29319612
DOI: 10.1097/TP.0000000000002037

Comment

Mitigating Risk of Immunosuppression by Immune Monitoring: Are We There?

Andrew Bentall et al. Transplantation. 2018 Mar.

. 2018 Mar;102(3):349-350.

doi: 10.1097/TP.0000000000002037.

Authors

Andrew Bentall¹, Hatem Amer¹

Affiliation

¹ Division of Nephrology and Hypertension, and the William J von Liebig Center for Transplantation and Clinical Regeneration, Mayo Clinic, Rochester, MN.

PMID: 29319612
DOI: 10.1097/TP.0000000000002037

No abstract available

PubMed Disclaimer

Comment on

Improved Pulse Wave Velocity and Renal Function in Individualized Calcineurin Inhibitor Treatment by Immunomonitoring: The Randomized Controlled Calcineurin Inhibitor-Sparing Trial.
Sommerer C, Brocke J, Bruckner T, Schaier M, Morath C, Meuer S, Zeier M, Giese T. Sommerer C, et al. Transplantation. 2018 Mar;102(3):510-520. doi: 10.1097/TP.0000000000001973. Transplantation. 2018. PMID: 29077654 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wolters Kluwer
Other Literature Sources
- scite Smart Citations